initi
step
human
immunodefici
viru
hiv
replic
cycl
play
crucial
role
arbitr
viral
tropism
infect
effici
releas
genom
host
cell
cytoplasm
virus
oper
complex
sequenc
event
take
place
plasma
membran
target
cell
first
step
bind
hiv
protein
envelop
env
cellular
receptor
trigger
conform
chang
viral
protein
allow
interact
coreceptor
either
defin
tropism
viru
enter
cell
sequenti
interact
final
drive
fusion
viral
host
cell
membran
endocytosi
virus
discuss
membran
composit
organ
viru
target
cell
affect
step
thu
influenc
capabl
virus
infect
cell
entri
viru
cell
decompos
three
main
success
step
interact
virus
specif
receptor
interact
virus
coreceptor
either
fusion
membran
viru
one
infect
cell
endocytosi
viru
fig
effici
step
influenc
membran
protein
lipid
composit
later
organ
dynam
surfac
target
cell
shown
hiv
attach
immun
cell
first
occur
via
nonspecif
adhes
molecul
restrict
viru
envelop
vicin
specif
receptor
princip
mandatori
receptor
upon
bind
viral
protein
undergo
conform
chang
allow
addit
interact
coreceptor
step
main
paramet
affect
effici
first
step
densiti
receptor
present
surfac
target
cell
amount
vari
lot
cell
cell
type
e
macrophag
express
level
fold
lower
cell
e
also
depend
activ
state
immun
cell
reason
huge
variabl
infect
efficaci
depend
viru
strain
cell
type
infect
render
difficult
interpret
comparison
experi
carri
differ
studi
beyond
express
level
second
factor
taken
account
later
organ
protein
well
known
later
organ
protein
plasma
membran
cell
heterogen
might
depend
lipid
composit
context
mani
laboratori
observ
protein
randomli
distribut
surfac
plasma
membran
cell
rather
confin
domain
cluster
may
promot
hiv
bind
sinc
virus
could
engag
sever
interact
multipl
confin
small
area
shown
partial
locat
lipid
raft
lipid
raft
microdomain
result
preferenti
associ
sphingolipid
satur
lipid
sterol
specif
protein
extern
leaflet
plasma
membran
microdomain
found
liquidord
state
lo
render
resist
solubil
deterg
low
temperatur
grow
amount
evid
presenc
cholesterol
target
cell
essenti
infect
mani
virus
ebola
viru
herp
simplex
murin
coronaviru
requir
cholesterol
target
cell
membran
long
controversi
start
begin
millennium
know
whether
hiv
preferenti
bind
protein
confin
lipid
raft
put
role
lipid
raft
first
came
observ
cholesterol
deplet
impair
hiv
infect
similar
result
also
obtain
use
glucosylceramid
synthas
inhibitor
block
glycosphingolipid
biosynthesi
nevertheless
approach
present
two
drawback
first
treatment
stress
cell
one
sure
observ
effect
result
sole
decreas
cholesterol
content
second
reveal
step
lipid
raft
might
involv
infect
process
receptor
coreceptor
bind
go
comprehens
role
lipid
raft
hiv
infect
deterg
extract
optic
microscopi
studi
use
produc
contradictori
result
exampl
one
studi
show
mutant
exclud
lipid
raft
domain
membran
allow
effici
hiv
entri
wherea
similar
studi
use
altern
mutant
also
prevent
associ
lipid
raft
establish
exclud
lipid
raft
support
hiv
entri
two
studi
carri
differ
cell
type
hek
cell
respect
cell
line
like
differ
lipid
composit
organ
might
explain
discrep
result
describ
also
enlighten
crucial
role
membran
composit
organ
mechan
infect
process
appar
contradict
also
aris
work
publish
author
success
show
hiv
use
lipid
raftcoloc
product
entri
cell
receptor
local
nonraft
membran
microdomain
support
entri
one
hypothesi
render
puzzl
observ
compat
take
consider
studi
probe
differ
step
infect
process
ie
bind
receptor
bind
coreceptor
fusion
propos
lipid
raft
local
requir
viru
bind
follow
step
depend
presenc
lipid
raft
hypothesi
reinforc
lead
exposur
coreceptor
bind
site
coreceptor
depend
viru
tropism
coreceptor
either
tropism
tropism
coreceptor
bind
trigger
new
conform
chang
expos
protein
insert
membran
host
cell
protein
bend
back
form
six
helix
bundl
bring
closer
viral
target
cell
membran
lead
fusion
altern
pathway
fusion
entri
viru
cell
host
via
endocytosi
viru
particl
degrad
fuse
vesicular
membran
releas
viru
content
cytoplasm
cell
observ
later
mobil
affect
envelop
glycoprotein
mediat
fusion
word
virus
bound
cell
surfac
might
migrat
lipid
raft
domain
infect
complet
furthermor
model
agreement
observ
murin
leukemia
viru
surf
surfac
infect
cell
preced
entri
show
differ
step
hiv
infect
occur
place
render
necessari
develop
dynam
approach
order
studi
timecours
infect
process
major
coreceptor
chemokin
receptor
use
coreceptor
defin
viral
tropism
strain
infect
cell
virus
use
coreceptor
call
use
name
use
term
virus
prevail
chronic
phase
infect
emerg
sever
year
half
patient
variant
capabl
use
associ
rapid
progress
toward
patholog
state
mechan
virus
emerg
precipit
diseas
progress
still
unknown
differ
studi
propos
infect
process
requir
attach
sever
envelop
trimer
multipl
multipl
coreceptor
consid
weak
interact
virus
short
time
less
encount
coreceptor
bound
viru
entri
might
thu
depend
local
membran
densiti
also
chemokin
receptor
local
densiti
expect
favor
sequestr
andor
delimit
membran
domain
support
highresolut
electron
microscopi
experi
show
cluster
microvilli
human
macrophag
cell
coimmunoprecipit
studi
shown
constitut
associ
surfac
cell
macrophag
monocyt
similar
studi
perform
hek
cell
show
opposit
constitut
interact
later
confirm
fret
experi
also
reveal
interact
take
place
outsid
lipid
raft
domain
reinforc
viral
protein
anoth
clue
interact
came
studi
membran
dynam
receptor
first
observ
present
differ
mobil
interestingli
shown
presenc
strongli
affect
dynam
inde
express
alon
hek
cell
one
diffus
popul
confin
larg
domain
detect
behavior
markedli
modifi
presenc
sinc
two
diffus
popul
observ
lead
conclus
interact
one
sever
lead
confin
smaller
membran
domain
absenc
confin
zone
concentr
might
constitut
platform
would
facilit
bind
andor
consecut
fusion
hiv
target
cell
preval
viru
strain
primoinfect
studi
concern
receptor
compar
studi
carri
protein
organ
within
membran
immun
cell
mani
work
concern
clinic
investig
coimmunoprecipit
studi
shown
constitut
associ
howev
studi
perform
hek
cell
transient
express
gave
contradictori
result
regard
mention
coreceptor
chapter
recent
public
respect
base
use
cyclodextrin
ceramid
modul
also
shown
protein
partial
local
lipid
raft
domain
local
lipid
raft
requir
effici
infect
even
though
literatur
contradictori
point
seem
clear
receptor
coreceptor
hiv
viru
confin
domain
could
act
port
entri
hiv
virus
exampl
illustr
fact
statin
inhibit
viru
infect
downregul
activ
rho
gtpase
expect
imped
cluster
host
lipid
rafteassoci
receptor
exist
differ
independ
confin
zone
might
also
give
explan
preval
expens
instanc
one
hypothes
preferenti
confin
microdomain
differ
hypothesi
agreement
observ
reduc
express
decreas
suscept
human
cell
infect
virus
furthermor
shown
lower
express
level
molecul
modul
cholesterol
content
lovastatin
mevastatin
simvastatin
favor
infect
virus
taken
togeth
result
rais
question
later
distribut
stoichiometri
differ
receptor
surfac
target
cell
recent
johnston
collabor
develop
affinofil
cell
express
level
independ
modul
sever
strain
stabli
express
variou
amount
gener
allow
obtain
ratio
tool
provid
power
method
character
viral
entri
effici
function
express
level
affinofil
cell
line
also
permit
demonstr
sever
conform
distinguish
thank
specif
monoclon
antibodi
exhibit
differ
local
gprotein
associ
might
implic
select
target
system
also
use
lab
check
whether
express
level
receptor
coreceptor
impact
dynam
infect
effici
variou
viru
strain
receptor
bind
subsequ
associ
coreceptor
lead
conform
chang
viral
trimer
protein
induc
exposur
hydrophob
peptid
insert
host
cell
membran
bring
closer
viral
host
membran
protein
bend
back
form
six
helix
bundl
stage
viral
membran
target
cell
membran
bypass
repuls
forc
close
enough
spontan
form
fusion
pore
role
lipid
modul
step
extens
studi
implic
lipid
raft
admit
research
first
shown
larg
unilamellar
vesicl
luv
sphingomyelin
cholesterol
promot
surfac
aggreg
membran
restructur
aggreg
thought
import
reach
stoichiometri
allow
fusion
occur
inde
propos
least
two
envelop
protein
bind
coreceptor
two
fusion
protein
trimer
insert
target
cell
promot
viral
entri
protein
present
extracellular
domain
contain
fusion
peptid
whose
structur
strongli
depend
lipid
environ
author
propos
small
amino
acid
sequenc
lwyik
within
protein
constitut
cholesterolbind
domain
import
hiv
infect
sequenc
present
homolog
cholesterol
recognit
aminoacid
consensu
crac
motif
describ
epand
work
realiz
model
membran
confirm
ectodomain
membran
proxim
region
abl
bind
cholesterol
membran
domain
bind
cholesterolrich
mol
zone
promot
bsheet
secondari
structur
fusion
peptid
deepli
emb
host
membran
deep
insert
shown
favor
fusogen
beyond
effect
insert
structur
viru
protein
cholesterol
might
play
role
membran
fusion
fusion
involv
coalesc
viral
host
cell
membran
accompani
mix
cytoplasm
impli
lipid
transient
adopt
nonlamellar
organ
describ
chernomordik
kozlov
organ
name
hemifus
stalk
stabil
invert
coneshap
andor
coneshap
lipid
depend
outer
inner
leaflet
locat
point
view
interest
note
hiv
membran
enrich
phopshoinositid
induc
posit
curvatur
favor
initi
fusion
cholesterol
might
mediat
membran
curvatur
host
cell
fusion
notic
effect
cholesterol
specif
hiv
fusion
process
observ
process
nuclear
membran
format
author
shown
sphingomyelin
play
role
hiv
infect
studi
base
surfac
aggreg
assay
rhodaminelabel
subunit
demonstr
sphingomyelin
cholesterol
promot
effect
sphingomyelinas
also
studi
extract
raft
viru
bind
assay
measur
dynam
hiv
receptor
author
observ
sphingomyelinas
treatment
decreas
later
mobil
inhibit
hiv
fusion
membran
target
cell
propos
effect
due
cluster
molecul
prevent
coreceptor
engag
hiv
fusion
notic
fusion
viral
membran
plasma
membran
target
cell
necessarili
conduc
product
infect
sinc
viral
content
degrad
insid
target
cell
furthermor
lipid
mix
viral
cell
membran
observ
without
releas
viral
content
insid
target
cell
incomplet
fusion
argument
favor
endocytot
pathway
discuss
follow
section
although
mechan
hiv
fusion
well
document
see
part
manuscript
sever
line
evid
suggest
hiv
entri
cell
host
also
occur
via
endocytosi
process
moreov
propos
predomin
hiv
intern
macrophag
endotheli
cell
epitheli
cell
also
shown
depend
cell
activ
statu
minireview
focus
role
specif
play
lipid
process
invit
reader
refer
recent
review
melikian
gener
discuss
endocytosi
versu
fusion
hiv
entri
kinet
measur
fusion
perform
differ
temperatur
use
specif
inhibitor
point
hiv
virus
enter
cell
via
endocytosi
follow
fusion
endosom
work
also
show
inhibit
endocytosi
allow
lipid
mix
viral
cell
membran
without
conduc
complet
fusion
interestingli
obtain
result
independ
viru
tropism
kinet
appear
depend
target
cell
type
might
due
differ
endosom
traffick
tempt
propos
variat
might
due
differ
lipid
composit
cell
line
exampl
similar
experi
markosyan
collabor
propos
membran
tension
might
differ
cell
type
affect
pore
format
growth
studi
base
cholesterol
disrupt
macrophag
membran
demonstr
hiv
entri
macrophag
depend
lipid
raft
later
confirm
studi
show
endocytosi
hiv
involv
raft
origin
work
come
fact
use
pharmacolog
agent
may
nonspecif
effect
thank
genet
modifi
macrophag
allow
manipul
subcellular
distribut
author
entri
hiv
macrophag
depend
endocytosi
lipid
raft
contain
work
carri
specif
studi
role
lipid
hiv
endocytosi
interest
go
field
one
difficulti
understand
hiv
infect
mechan
come
fact
differ
entri
pathway
exist
import
still
subject
controversi
sinc
hiv
particl
degrad
cell
small
fraction
virus
establish
infect
identif
product
entri
pathway
remain
difficult
howev
whatev
mode
entri
virus
mani
observ
suggest
membran
composit
organ
play
import
role
cholesterol
sphingomyelin
lipid
raft
domain
seem
first
import
infect
process
also
viru
preval
glycosphingolipid
gangliosid
also
report
facilit
hiv
infect
galactosylceramid
lipid
might
serv
hiv
bind
site
regul
dynam
cluster
inform
recent
reinforc
fact
peptid
conjug
lipid
compris
sphingomyelin
backbon
impair
earli
late
membran
fusion
context
develop
new
origin
noninvas
techniqu
allow
discrimin
entri
pathway
virus
deciph
molecular
mechan
involv
infect
process
among
singl
particl
track
techniqu
promis
use
studi
dynam
organ
hiv
receptor
coreceptor
reveal
exist
subpopul
differ
behavior
tlymphocyt
track
entir
virus
consist
label
virus
fluoresc
probe
record
movement
videomicroscop
might
use
studi
timecours
infect
process
approach
give
inform
regard
percentag
abort
bind
ie
viru
bind
without
encount
coreceptor
final
unbind
also
permit
measur
timelaps
bind
cell
surfac
viru
target
cell
membran
fusion
two
paramet
give
real
time
insight
onto
effici
infect
process
method
use
verifi
previous
obtain
data
behavior
singl
protein
physiolog
relev
context
approach
alreadi
success
use
influenza
virus
might
extend
inactiv
hiv
virus
keep
bind
fusion
properti
combin
use
drug
modul
lipid
membran
composit
techniqu
permit
understand
mechan
involv
infect
specif
role
play
lipid
process
